412
Views
11
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma

, PhDORCID Icon, , MSc & , MD
Pages 2016-2023 | Received 10 May 2021, Accepted 19 Sep 2021, Published online: 12 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jefferson Antonio Buendía, Diana Guerrero Patiño & Andrés Felipe Zuluaga Salazar. (2024) Cost effectiveness of omalizumab for severe asthma in Colombia. Journal of Asthma 61:4, pages 292-299.
Read now
Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young & Nathorn Chaiyakunapruk. (2023) Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies. Journal of Asthma 60:9, pages 1702-1714.
Read now
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2023) Tiotropium for children and adolescents with severe asthma. Journal of Asthma 60:5, pages 1009-1015.
Read now
Jefferson Antonio Buendía, Carlos E. Rodriguez-Martinez & Monica P. Sossa-Briceño. (2023) Cost utility of vitamin D supplementation in adults with mild to moderate asthma. Journal of Asthma 60:5, pages 951-959.
Read now
Jefferson Antonio Buendía,Diana Guerrero Patiño. (2023) Fluticasone furoate plus vilanterol in patients with moderate persistent asthma: a cost-utility analysis. Journal of Asthma 60:2, pages 377-384.
Read now

Articles from other publishers (6)

Ashna Mehra, Rebecca Grohman, Sohini Shah & Anna Nowak-Węgrzyn. (2023) Food Allergy: Emerging Therapies. Current Treatment Options in Allergy 10:3, pages 319-339.
Crossref
Jefferson Antonio Buendía, Ricardo Hernández-Sarmiento & Jorge Enrique Rojas Medina. (2023) Cost-Utility of Continuous Positive Airway Pressure for Respiratory Distress in Preterm Infants in a Middle-Income Country. Value in Health Regional Issues 35, pages 1-7.
Crossref
Jefferson A. Buendía & Diana G. Patiño. (2022) Dupilumab in children with moderate‐to‐severe asthma: A cost utility analysis. Pediatric Pulmonology 57:10, pages 2313-2319.
Crossref
Jason R. Burchett, Jordan M. Dailey, Sydney A. Kee, Destiny T. Pryor, Aditya Kotha, Roma A. Kankaria, David B. Straus & John J. Ryan. (2022) Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing. Cells 11:19, pages 3031.
Crossref
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2021) Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma. BMC Pulmonary Medicine 21:1.
Crossref
Jefferson Antonio Buendía & Diana Guerrero Patiño. (2021) Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma. BMC Pulmonary Medicine 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.